Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

NCT06567860 is registered in ClinicalTrials.gov with La Jolla Institute for Immunology as lead sponsor.

NCT NCT06567860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06567860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations
Lead sponsor
La Jolla Institute for Immunology
Phase
Phase 4
Overall status
Completed
Start date
May 21, 2024
Completion date
February 6, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a